Prevalence of Staphylococcus aureus and antibiotic resistance in children with atopic dermatitis: A New Zealand experience

Australasian Journal of Dermatology

Volumn 52, Issue 1, 2011, Pages 27-31

  Hill, Sarah E ^a   Yung, Anthony ^a   Rademaker, Marius ^a  

^a WAIKATO HOSPITAL   (New Zealand)

Author keywords

Antibiotic resistance; Atopic dermatitis; MRSA; Paediatric; Staphylococcus aureus

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; DOXYCYCLINE; EMOLLIENT AGENT; ERYTHROMYCIN; FLUCLOXACILLIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATOPIC DERMATITIS; BACILLUS CEREUS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CAUCASIAN; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLIFORM BACTERIUM; DEMOGRAPHY; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MAORI; MEDICAL AUDIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEW ZEALAND; NONHUMAN; OBSERVATIONAL STUDY; PACIFIC ISLANDER; PRESCHOOL CHILD; PROSPECTIVE STUDY; RATING SCALE; RISK ASSESSMENT; SCHOOL CHILD; SCORING ATOPIC DERMATITIS; SEX DIFFERENCE; SKIN CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; TOPICAL TREATMENT;

ANTI-BACTERIAL AGENTS; CHILD; DERMATITIS, ATOPIC; DRUG RESISTANCE, MICROBIAL; FEMALE; FLOXACILLIN; HUMANS; MALE; NEW ZEALAND; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79952053411     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00714.x     Document Type: Article

References (19)

1. Matsui K, Nishikawa A, Suto H et al. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients. Microbiol. Immunol. 2000; 44: 945-7.
2. Higaki S, Morohashi M, Yamagishi T et al. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int. J. Dermatol. 1999; 38: 265-9.
3. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
4. Finger F, Rossaak M, Umstaetter R et al. Skin infections of the limbs of Polynesian children. N. Z. Med. J. 2004; 117: U847.
5. Heffernan H, Richardson A, Woodhouse R. Annual survey of methicillin-resistant Staphylococcus aureus (MRSA). 2008. Available from URL: http://www.surv.esr.cri.nz/PDF-surveillance/Antimicrobial/MRSA-2/aMRSA-2008.pdf. (Accessed 26 Jan 2010).
6. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 2010; 23: 616-87.
7. Population Health Workforce. Population Health Planning Resource 2007-2012. Available from URL: http://www.waikatodhb.govt.nz/page/pageid/ 2145838658 (Accessed 24 Jan 2010).
8. Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J. Antimicrob. Chemother. 2003; 51: 613-7.
9. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. 1980; 92: 44-7.
10. CLSI. 2007. Performance Standards for Antimicrobial Susceptibility Testing. 15th Informational Supplement. Approved standard M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Waikato District Health Board Health Needs Assessment and Analysis 2008. Chapter 3. Demographics. Available from URL: http://www.waikatodhb.govt.nz/file/ fileid/9306 (Accessed 25 July 2010).
12. Gong JQ, Lin L, Lin T et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br. J. Dermatol. 2006; 155: 680-7.
13. Farajzadeh S, Rahnama Z, Kamyabi Z et al. Bacterial colonization and antibiotic resistance in children with atopic dermatitis. Dermatol. Online J. 2008; 14: 21.
14. Chiu LS, Ho MS, Hsu LY et al. Prevalence and molecular characteristics of Staphylococcus aureus isolates colonizing patients with atopic dermatitis and their close contacts in Singapore. Br. J. Dermatol. 2009; 160: 965-71. Epub 2009 Feb 16.
15. Bonness S, Szekat C, Novak N et al. Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar isolates in isolates from children and their parents. J. Clin. Microbiol. 2008; 46: 456-61.
16. Huang JT, Abram M, Thougan B et al. Treatment of Staphylococcus aureus colonization in Atopic Dermatitis Decreases Disease Severity. Pediatrics 2009; 5: 808-15.
17. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC et al. Interventions to reduce Staphylococcal aureus in the management of atopic eczema. Cochrane Database Syst. Rev. 2008; (3): CD003871. DOI: 10.1002/14651858.CD003871.pub2.
18. Chung HJ, Jeon HS, Sung H et al. Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J. Clin. Microbiol. 2008; 46: 991-5.
19. Suh L, Coffin S, Leckerman KH et al. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis. Pediatr. Dermatol. 2008; 25: 528-34.